China Treasures New Materials (2439) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
15 Oct, 2026Executive summary
FY2024 revenue rose 11.4% to RMB407.5m; profit for the year increased 32.9% to RMB112.4m, supported by higher gross profit and other income and lower listing expenses.
Production plans shifted toward Changchun, with Dongguan and Anji operations being consolidated and a new self-owned production base planned on land acquired in Changchun.
Financial highlights
Revenue was RMB407.5m versus RMB365.8m; gross profit RMB162.0m versus RMB145.5m, with gross margin steady at 39.8%.
Profit before tax was RMB131.8m versus RMB100.1m; profit for the year was RMB112.4m versus RMB84.6m.
Profit attributable to owners was RMB111.2m versus RMB84.0m; basic and diluted EPS was RMB11.12 versus RMB8.80.
Other income increased to RMB20.3m from RMB7.3m, including RMB9.8m in government grants and a RMB7.9m additional lease-payment refund.
Income tax expense rose to RMB19.4m from RMB15.5m, mainly reflecting higher profit before tax.
Outlook and guidance
Prospects for biodegradable products were described as optimistic, with demand supported by expanding PRC restrictions on non-biodegradable plastics and changing consumption habits.
The prohibition on non-degradable plastic bags is expected to expand to various marketplaces by end-2025; market demand has increased as policies extend to more provinces.
Changchun is the planned production cornerstone, intended to support capacity growth, cost competitiveness, supply-chain efficiency and service to Northeast China customers.
Unutilized IPO proceeds allocated to the new Changchun production base, R&D equipment, IT systems and biodegradable production-line expansion are expected to be used by December 2025; working capital use is as needed.
Latest events from China Treasures New Materials
- Biodegradable demand lifted H1 revenue as cost inflation trimmed gross margin.2439
H1 2023 - Biodegradable product growth lifted FY2023 profit 48.5% as expansion advanced and margins eased.2439
H2 2023 - Revenue and profit grew as policy-led biodegradable demand offset expansion and production risks.2439
H1 2024 - Online-led demand weakness cut H1 profit as Changchun expansion lifted leverage.2439
H1 2025 - Revenue and profit contracted sharply as the new Changchun base neared operations.2439
H2 2025 - H1 profit fell 47.8% as weaker demand and new-base costs pressured margins.2439
H1 2026